Inhibition of TGF-beta expression: a novel role for thiazolidinediones to implement renoprotection in diabetes
- PMID: 18046419
- DOI: 10.1038/sj.ki.5002654
Inhibition of TGF-beta expression: a novel role for thiazolidinediones to implement renoprotection in diabetes
Abstract
Actual strategies to delay progression of diabetic nephropathy provide imperfect protection when started late in the course of the disease. Ohtomo et al. now demonstrate that thiazolidinedione treatment was associated with a remarkable improvement in proteinuria and renal function, offering a new potential treatment for diabetic nephropathy.
Comment in
-
Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model.Kidney Int. 2007 Dec;72(12):1512-9. doi: 10.1038/sj.ki.5002570. Epub 2007 Sep 26. Kidney Int. 2007. PMID: 17898696
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
